mRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis & Characterization], Instrument), Service (Synthesis, Purification, Manufacturing & Scale-up), Application (CGT, Vaccines) - Global Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 GLOBAL MARKET SIZE ESTIMATION
  • 2.2.2 INSIGHTS FROM PRIMARY SOURCES
  • 2.2.3 TOP-DOWN APPROACH
• 2.3 GROWTH RATE PROJECTIONS
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 MRNA SYNTHESIS & MANUFACTURING MARKET OVERVIEW
• 4.2 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT AND COUNTRY, 2023
• 4.3 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: GLOBAL GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rise in clinical trials for mRNA vaccines
    • 5.2.1.2 Continuous improvements in design, delivery systems, and manufacturing processes
    • 5.2.1.3 Increased outsourcing of mRNA synthesis and production
    • 5.2.1.4 Advantages of mRNA-based technology over recombinant expression
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High production cost
    • 5.2.2.2 Stringent regulations
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Ongoing innovations in nanoparticles and cell-specific delivery technologies
    • 5.2.3.2 Expanding applications of mRNA technology
    • 5.2.3.3 Increased government funding and private investments
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Stability, storage, and manufacturing scalability issues
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 REGULATORY LANDSCAPE
  • 5.4.1 REGULATORY SCENARIO
  • 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 In vitro transcription
    • 5.6.1.2 Poly(A) tail synthesis
    • 5.6.1.3 RNA stabilization technologies
  • 5.6.2 COMPLEMENTARY TECHNOLOGIES
    • 5.6.2.1 Next-generation sequencing
    • 5.6.2.2 Gene cloning and vector construction
    • 5.6.2.3 DNA amplification
  • 5.6.3 ADJACENT TECHNOLOGIES
    • 5.6.3.1 Spectrophotometry
    • 5.6.3.2 Electrophoresis
    • 5.6.3.3 High-performance liquid chromatography
• 5.7 PRICING ANALYSIS
  • 5.7.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT
  • 5.7.2 AVERAGE SELLING PRICE TREND FOR CONSUMABLES
  • 5.7.3 AVERAGE SELLING PRICE, BY REGION
• 5.8 PATENT ANALYSIS
• 5.9 SUPPLY CHAIN ANALYSIS
• 5.10 ECOSYSTEM ANALYSIS
• 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.12.2 BARGAINING POWER OF SUPPLIERS
  • 5.12.3 BARGAINING POWER OF BUYERS
  • 5.12.4 THREAT OF SUBSTITUTES
  • 5.12.5 THREAT OF NEW ENTRANTS
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 KEY BUYING CRITERIA, BY END USER (PRODUCT)
• 5.14 INVESTMENT AND FUNDING SCENARIO
• 5.15 IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET

6 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 CONSUMABLES
  • 6.2.1 TRANSCRIPTION CONSUMABLES
    • 6.2.1.1 mRNA synthesis kits
      • 6.2.1.1.1 Increasing demand for rapid and efficient mRNA vaccine development to augment growth
    • 6.2.1.2 mRNA profiling kits
      • 6.2.1.2.1 Growing need for precision medicine and personalized therapies to propel market
    • 6.2.1.3 RNA polymerases
      • 6.2.1.3.1 Growing demand for high-quality and scalable mRNA production to boost market
    • 6.2.1.4 Plasmid DNA/DNA templates
      • 6.2.1.4.1 Rapid growth of mRNA-based therapeutics and vaccines to expedite growth
    • 6.2.1.5 Nucleotides
      • 6.2.1.5.1 Need to support diverse research & development initiatives to promote growth
    • 6.2.1.6 Vectors
      • 6.2.1.6.1 Need for reliable and high-capacity vectors to propel market
    • 6.2.1.7 Other transcription consumables
  • 6.2.2 PURIFICATION CONSUMABLES
    • 6.2.2.1 Purification kits & reagents
      • 6.2.2.1.1 Rising focus on quality assurance to encourage growth
    • 6.2.2.2 Chromatography filters & membranes
      • 6.2.2.2.1 Growing emphasis on process optimization and cost-efficiency in large-scale production to drive market
    • 6.2.2.3 Other purification consumables
  • 6.2.3 ANALYSIS & CHARACTERIZATION CONSUMABLES
    • 6.2.3.1 Analysis kits & reagents
      • 6.2.3.1.1 Emerging applications of mRNA beyond vaccines to support growth
    • 6.2.3.2 Other analysis & characterization consumables
• 6.3 INSTRUMENTS
  • 6.3.1 NEED TO REDUCE PRODUCTION COST AND HIGHER SCALABILITY TO PROMOTE GROWTH

7 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 CELL & GENE THERAPIES
  • 7.2.1 RISING ADOPTION OF MRNA TECHNOLOGY TO TREAT GENETIC DISORDERS AND CANCER TO FUEL MARKET
• 7.3 VACCINES
  • 7.3.1 INCREASING DEVELOPMENT AND DEPLOYMENT OF MRNA VACCINES TO ACCELERATE GROWTH
• 7.4 OTHER APPLICATIONS

8 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 8.2.1 NEED TO RESPOND TO EMERGING INFECTIOUS DISEASES TO DRIVE MARKET
• 8.3 ACADEMIC & RESEARCH INSTITUTIONS
  • 8.3.1 INCREASING INVESTMENTS IN RESEARCH TO EXPEDITE GROWTH
• 8.4 CROS & CDMOS
  • 8.4.1 RISING DEMAND FOR OUTSOURCED SERVICES TO AID GROWTH

9 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE

• 9.1 INTRODUCTION
• 9.2 MRNA SYNTHESIS & MODIFICATION SERVICES
  • 9.2.1 GROWING NEED FOR CUSTOMIZED MRNA SEQUENCES AND MODIFICATIONS TO FUEL MARKET
• 9.3 MRNA PURIFICATION SERVICES
  • 9.3.1 NEED FOR PERSONALIZED MRNA VACCINES TO BOOST MARKET
• 9.4 MRNA ANALYSIS & CHARACTERIZATION SERVICES
  • 9.4.1 INCREASING REGULATORY SCRUTINY TO EXPEDITE GROWTH
• 9.5 MANUFACTURING & SCALE-UP SERVICES
  • 9.5.1 GROWING TRANSITION FROM SMALL-SCALE RESEARCH & DEVELOPMENT TO LARGE-SCALE COMMERCIAL PRODUCTION TO DRIVE MARKET

10 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.2.1 RAPID DEVELOPMENT AND COMMERCIALIZATION OF MRNA-BASED PRODUCTS TO ENCOURAGE GROWTH
• 10.3 ACADEMIC & RESEARCH INSTITUTIONS
  • 10.3.1 INCREASING EMPHASIS ON TRANSLATING MRNA-BASED DISCOVERIES INTO PRACTICAL APPLICATIONS TO AID GROWTH
• 10.4 SMALL-SCALE CROS & CDMOS
  • 10.4.1 NEED FOR SPECIALIZED AND FLEXIBLE PRODUCTION IN BIOTECH COMPANIES AND EARLY-STAGE MRNA PROJECTS TO BOOST MARKET

11 MRNA SYNTHESIS & MANUFACTURING MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Increasing demand for mRNA-based vaccines and therapeutics to accelerate growth
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing collaborations between academic institutions and market players to spur growth
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Growing establishment of manufacturing sites to boost market
  • 11.3.3 UK
    • 11.3.3.1 Presence of state-of-the-art facilities to support growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Favorable government support for biopharmaceutical production to drive market
  • 11.3.5 SWITZERLAND
    • 11.3.5.1 Robust biotech sector and production facilities to promote growth
  • 11.3.6 ITALY
    • 11.3.6.1 Increasing collaborations among biotech firms and manufacturing facilities to aid growth
  • 11.3.7 SPAIN
    • 11.3.7.1 Growing investments in biotechnology to fuel market
  • 11.3.8 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Rapid expansion of domestic biotech sector to contribute to growth
  • 11.4.3 JAPAN
    • 11.4.3.1 Growing strategic investments in biotechnology infrastructure to boost market
  • 11.4.4 INDIA
    • 11.4.4.1 Booming biotech sector and international collaborations to augment growth
  • 11.4.5 SOUTH KOREA
    • 11.4.5.1 Increased government funding in research and vaccine development to bolster growth
  • 11.4.6 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Increased funding for strengthening infrastructure to sustain growth
  • 11.5.3 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST
  • 11.6.1 GROWING INVESTMENTS FROM PRIVATE SECTOR AND ACADEMIC RESEARCH INITIATIVES TO DRIVE MARKET
  • 11.6.2 MACROECONOMIC OUTLOOK IN MIDDLE EAST
• 11.7 AFRICA
  • 11.7.1 GROWING INITIATIVES TO ENHANCE LOCAL PRODUCTION CAPABILITIES TO PROPEL MARKET
  • 11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021-AUGUST 2024
• 12.3 REVENUE ANALYSIS, 2019-2023
• 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.4.1 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET
  • 12.4.2 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND/SERVICE COMPARISON
  • 12.6.1 ALDEVRON LLC (DANAHER CORPORATION) (US)
  • 12.6.2 THERMO FISHER SCIENTIFIC INC. (US)
  • 12.6.3 TRILINK BIOTECHNOLOGIES (US)
  • 12.6.4 LONZA (SWITZERLAND)
  • 12.6.5 MERCK KGAA (GERMANY)
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Region footprint
    • 12.7.5.3 Product footprint
    • 12.7.5.4 Service footprint
    • 12.7.5.5 Application footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of key startups/SMES
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT/SERVICE LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 THERMO FISHER SCIENTIFIC INC.
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product/Service launches
      • 13.1.1.3.2 Deals
      • 13.1.1.3.3 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 DANAHER CORPORATION
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product/Service launches
      • 13.1.2.3.2 Deals
      • 13.1.2.3.3 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 MERCK KGAA
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Deals
      • 13.1.3.3.2 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 LONZA
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Deals
      • 13.1.4.3.2 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 MARVAI LIFESCIENCES
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product/Service launches
      • 13.1.5.3.2 Deals
      • 13.1.5.3.3 Expansions
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Key strengths
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses and competitive threats
  • 13.1.6 NEW ENGLAND BIOLABS
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product/Service launches
  • 13.1.7 PROMEGA CORPORATION
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Expansions
      • 13.1.7.3.2 Other developments
  • 13.1.8 GENSCRIPT
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product/Service launches
      • 13.1.8.3.2 Deals
      • 13.1.8.3.3 Expansions
    • 13.1.8.4 MnM view
      • 13.1.8.4.1 Key strengths
      • 13.1.8.4.2 Strategic choices
      • 13.1.8.4.3 Weaknesses and competitive threats
  • 13.1.9 WUXI BIOLOGICS
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Expansions
  • 13.1.10 TAKARA BIO INC.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product/Service launches
      • 13.1.10.3.2 Deals
  • 13.1.11 SARTORIUS AG
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
  • 13.1.12 GENEWIZ
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Services offered
  • 13.1.13 TELESIS BIO INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Services offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Product/Service launches
      • 13.1.13.3.2 Deals
  • 13.1.14 ST PHARM
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products/Services offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Deals
  • 13.1.15 AGC BIOLOGICS
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products/Services offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Deals
      • 13.1.15.3.2 Expansions
  • 13.1.16 DR. REDDY'S LABORATORIES LTD.
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products/Services offered
    • 13.1.16.3 Recent developments
      • 13.1.16.3.1 Expansions
• 13.2 OTHER PLAYERS
  • 13.2.1 ETHERNA
  • 13.2.2 BOC SCIENCES
  • 13.2.3 BIOMAY AG
  • 13.2.4 CURIA GLOBAL, INC.
  • 13.2.5 JENA BIOSCIENCE GMBH
  • 13.2.6 ENZYNOMICS CO., LTD.
  • 13.2.7 KANEKA EUROGENTEC S.A.
  • 13.2.8 VERNAL BIOSCIENCES
  • 13.2.9 CELLSCRIPT

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

List of Tables

• TABLE 1 MRNA SYNTHESIS & MANUFACTURING MARKET: INCLUSIONS AND EXCLUSIONS
• TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
• TABLE 3 MRNA SYNTHESIS & MANUFACTURING MARKET: RISK ANALYSIS
• TABLE 4 MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
• TABLE 5 INDICATIVE LIST OF MRNA VACCINES IN CLINICAL TRIALS (AS OF JUNE 2023)
• TABLE 6 INDICATIVE LIST OF MRNA-BASED DRUGS IN CLINICAL TRIALS (AS OF JUNE 2023)
• TABLE 7 REGULATORY SCENARIO FOR MRNA SYNTHESIS & MANUFACTURING MARKET WORLDWIDE
• TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 12 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT, 2021-2023 (USD)
• TABLE 13 AVERAGE SELLING PRICE TREND FOR CONSUMABLES, 2021-2023 (USD)
• TABLE 14 AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
• TABLE 15 MRNA SYNTHESIS & MANUFACTURING MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021-2024
• TABLE 16 MRNA SYNTHESIS & MANUFACTURING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 17 MRNA SYNTHESIS & MANUFACTURING MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
• TABLE 18 MRNA SYNTHESIS & MANUFACTURING MARKET: IMPACT OF PORTER'S FIVE FORCES
• TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
• TABLE 20 KEY BUYING CRITERIA, BY PRODUCT END USER
• TABLE 21 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 22 MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 23 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 24 EUROPE: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 25 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 26 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 27 MRNA SYNTHESIS & MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 28 TRANSCRIPTION CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 29 TRANSCRIPTION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 30 NORTH AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 31 EUROPE: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 32 ASIA PACIFIC: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 33 LATIN AMERICA: TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 34 MRNA SYNTHESIS KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 35 NORTH AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 36 EUROPE: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 37 ASIA PACIFIC: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 38 LATIN AMERICA: MRNA SYNTHESIS KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 39 MRNA PROFILING KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 40 NORTH AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 41 EUROPE: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 42 ASIA PACIFIC: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 43 LATIN AMERICA: MRNA PROFILING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 44 RNA POLYMERASES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 45 NORTH AMERICA: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 46 EUROPE: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 47 ASIA PACIFIC: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 48 LATIN AMERICA: RNA POLYMERASES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 49 PLASMID DNA/DNA TEMPLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 50 NORTH AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 51 EUROPE: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 52 ASIA PACIFIC: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 53 LATIN AMERICA: PLASMID DNA/DNA TEMPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 54 NUCLEOTIDES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 55 NORTH AMERICA: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 56 EUROPE: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 57 ASIA PACIFIC: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 58 LATIN AMERICA: NUCLEOTIDES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 59 VECTORS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 60 NORTH AMERICA: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 61 EUROPE: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 62 ASIA PACIFIC: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 63 LATIN AMERICA: VECTORS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 64 OTHER TRANSCRIPTION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 65 NORTH AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 66 EUROPE: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 67 ASIA PACIFIC: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 68 LATIN AMERICA: OTHER TRANSCRIPTION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 69 PURIFICATION CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 70 PURIFICATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 71 NORTH AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 72 EUROPE: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 73 ASIA PACIFIC: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 74 LATIN AMERICA: PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 75 PURIFICATION KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 76 NORTH AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 77 EUROPE: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 78 ASIA PACIFIC: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 79 LATIN AMERICA: PURIFICATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 80 CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 81 NORTH AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 82 EUROPE: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 83 ASIA PACIFIC: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 84 LATIN AMERICA: CHROMATOGRAPHY FILTERS & MEMBRANES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 85 OTHER PURIFICATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 86 NORTH AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 87 EUROPE: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 88 ASIA PACIFIC: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 89 LATIN AMERICA: OTHER PURIFICATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 90 ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 91 ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 92 NORTH AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 93 EUROPE: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 94 ASIA PACIFIC: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 95 LATIN AMERICA: ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 96 ANALYSIS KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 97 NORTH AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 98 EUROPE: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 99 ASIA PACIFIC: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 100 LATIN AMERICA: ANALYSIS KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 101 OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 102 NORTH AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 103 EUROPE: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 104 ASIA PACIFIC: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 105 LATIN AMERICA: OTHER ANALYSIS & CHARACTERIZATION CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 106 MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 107 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 108 EUROPE: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 109 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 110 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 111 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 112 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 113 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 114 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 115 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 116 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CELL & GENE THERAPIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 117 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 118 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 119 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 120 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 121 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR VACCINES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 122 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 123 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 124 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 125 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 126 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 127 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 128 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 129 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 130 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 131 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 132 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 133 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 134 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 135 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 136 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 137 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 138 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 139 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 140 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 141 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 142 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 143 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 144 MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 145 NORTH AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 146 EUROPE: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 147 ASIA PACIFIC: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 148 LATIN AMERICA: MRNA SYNTHESIS & MODIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 149 MRNA PURIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 150 NORTH AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 151 EUROPE: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 152 ASIA PACIFIC: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 153 LATIN AMERICA: MRNA PURIFICATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 154 MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 155 NORTH AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 156 EUROPE: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 157 ASIA PACIFIC: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 158 LATIN AMERICA: MRNA ANALYSIS & CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 159 MANUFACTURING & SCALE-UP SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 160 NORTH AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 161 EUROPE: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 162 ASIA PACIFIC: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 163 LATIN AMERICA: MANUFACTURING & SCALE-UP SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 164 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 165 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 166 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 167 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 168 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 169 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 170 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 171 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 172 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 173 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 174 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 175 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 176 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 177 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 178 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 179 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET FOR SMALL-SCALE CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 180 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 181 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 182 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 183 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 184 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 185 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 186 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 187 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 188 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 189 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 190 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 191 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 192 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 193 MACROECONOMIC INDICATORS FOR NORTH AMERICA
• TABLE 194 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 195 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 196 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 197 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 198 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 199 US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 200 US: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 201 US: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 202 US: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 203 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 204 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 205 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 206 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 207 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 208 CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 209 CANADA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 210 CANADA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 211 CANADA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 212 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 213 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 214 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 215 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 216 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 217 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 218 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 219 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 220 EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 221 EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 222 EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 223 MACROECONOMIC INDICATORS FOR EUROPE
• TABLE 224 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 225 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 226 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 227 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 228 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 229 GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 230 GERMANY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 231 GERMANY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 232 GERMANY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 233 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 234 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 235 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 236 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 237 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 238 UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 239 UK: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 240 UK: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 241 UK: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 242 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 243 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 244 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 245 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 246 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 247 FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 248 FRANCE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 249 FRANCE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 250 FRANCE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 251 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 252 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 253 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 254 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 255 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 256 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 257 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 258 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 259 SWITZERLAND: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 260 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 261 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 262 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 263 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 264 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 265 ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 266 ITALY: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 267 ITALY: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 268 ITALY: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 269 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 270 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 271 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 272 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 273 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 274 SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 275 SPAIN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 276 SPAIN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 277 SPAIN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 278 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 279 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 280 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 281 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 282 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 283 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 284 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 285 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 286 REST OF EUROPE: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 287 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 288 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 289 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 290 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 291 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 292 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 293 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 294 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 295 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 296 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 297 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 298 MACROECONOMIC INDICATORS FOR ASIA PACIFIC
• TABLE 299 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 300 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 301 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 302 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 303 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 304 CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 305 CHINA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 306 CHINA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 307 CHINA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 308 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 309 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 310 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 311 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 312 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 313 JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 314 JAPAN: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 315 JAPAN: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 316 JAPAN: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 317 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 318 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 319 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 320 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 321 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 322 INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 323 INDIA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 324 INDIA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 325 INDIA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 326 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 327 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 328 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 329 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 330 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 331 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 332 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 333 SOUTH KOREA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 334 SOUTH KOREA: MRNA SYNTHESIS AND MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 335 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 336 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 337 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 338 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 339 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 340 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 341 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 342 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 343 REST OF ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 344 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 345 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 346 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 347 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 348 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 349 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 350 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 351 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 352 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 353 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 354 LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 355 MACROECONOMIC INDICATORS FOR LATIN AMERICA
• TABLE 356 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 357 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 358 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 359 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 360 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 361 BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 362 BRAZIL: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 363 BRAZIL: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 364 BRAZIL: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 365 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 366 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 367 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 368 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 369 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 370 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 371 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 372 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 373 REST OF LATIN AMERICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 374 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 375 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 376 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 377 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 378 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 379 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 380 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 381 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 382 MIDDLE EAST: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 383 MACROECONOMIC INDICATORS FOR MIDDLE EAST
• TABLE 384 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 385 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 386 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY TRANSCRIPTION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 387 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY PURIFICATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 388 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY ANALYSIS & CHARACTERIZATION CONSUMABLES, 2022-2029 (USD MILLION)
• TABLE 389 AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 390 AFRICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 391 AFRICA: MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2022-2029 (USD MILLION)
• TABLE 392 AFRICA: MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 393 MACROECONOMIC INDICATORS FOR AFRICA
• TABLE 394 OVERVIEW OF STRATEGIES ADOPTED BY KEY MRNA SYNTHESIS & MANUFACTURING COMPANIES, JANUARY 2021-AUGUST 2024
• TABLE 395 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: DEGREE OF COMPETITION, 2023
• TABLE 396 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: RANKING ANALYSIS OF TOP 5 PLAYERS, 2023
• TABLE 397 MRNA SYNTHESIS & MANUFACTURING MARKET: REGION FOOTPRINT
• TABLE 398 MRNA SYNTHESIS & MANUFACTURING MARKET: PRODUCT FOOTPRINT
• TABLE 399 MRNA SYNTHESIS & MANUFACTURING MARKET: SERVICE FOOTPRINT
• TABLE 400 MRNA SYNTHESIS & MANUFACTURING MARKET: APPLICATION FOOTPRINT
• TABLE 401 MRNA SYNTHESIS & MANUFACTURING MARKET: KEY STARTUPS/SMES
• TABLE 402 MRNA SYNTHESIS AND MANUFACTURING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
• TABLE 403 MRNA SYNTHESIS & MANUFACTURING MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 404 MRNA SYNTHESIS & MANUFACTURING MARKET: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 405 MRNA SYNTHESIS & MANUFACTURING MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 406 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• TABLE 407 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
• TABLE 408 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 409 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 410 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 411 DANAHER CORPORATION: COMPANY OVERVIEW
• TABLE 412 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 413 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 414 DANAHER CORPORATION: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 415 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 416 MERCK KGAA: COMPANY OVERVIEW
• TABLE 417 MERCK KGAA: PRODUCTS/SERVICES OFFERED
• TABLE 418 MERCK KGAA: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 419 MERCK KGAA: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 420 LONZA: COMPANY OVERVIEW
• TABLE 421 LONZA: PRODUCTS/SERVICES OFFERED
• TABLE 422 LONZA: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 423 LONZA: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 424 MARVAI LIFESCIENCES: COMPANY OVERVIEW
• TABLE 425 MARVAI LIFESCIENCES: PRODUCTS/SERVICES OFFERED
• TABLE 426 MARVAI LIFESCIENCES: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 427 MARVAI LIFESCIENCE: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 428 MARVAI LIFESCIENCES: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 429 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
• TABLE 430 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED
• TABLE 431 NEW ENGLAND BIOLABS: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 432 PROMEGA CORPORATION: COMPANY OVERVIEW
• TABLE 433 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
• TABLE 434 PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 435 PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021-AUGUST 2024
• TABLE 436 GENSCRIPT: COMPANY OVERVIEW
• TABLE 437 GENSCRIPT: PRODUCTS/SERVICES OFFERED
• TABLE 438 GENSCRIPT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 439 GENSCRIPT: DEALS, JANUARY 2021- AUGUST 2024
• TABLE 440 GENSCRIPT: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 441 WUXI BIOLOGICS: COMPANY OVERVIEW
• TABLE 442 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED
• TABLE 443 WUXI BIOLOGICS: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 444 TAKARA BIO INC.: COMPANY OVERVIEW
• TABLE 445 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
• TABLE 446 TAKARA BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 447 TAKARA BIO INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 448 SARTORIUS AG: COMPANY OVERVIEW
• TABLE 449 SARTORIUS AG: PRODUCTS/SERVICES OFFERED
• TABLE 450 SARTORIUS AG: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 451 GENEWIZ: COMPANY OVERVIEW
• TABLE 452 GENEWIZ: PRODUCTS/SERVICES OFFERED
• TABLE 453 TELESIS BIO INC.: COMPANY OVERVIEW
• TABLE 454 TELESIS BIO INC.: PRODUCTS/SERVICES OFFERED
• TABLE 455 TELESIS BIO INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
• TABLE 456 TELESIS BIO INC.: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 457 ST PHARM: COMPANY OVERVIEW
• TABLE 458 ST PHARM: PRODUCTS/SERVICES OFFERED
• TABLE 459 ST PHARM: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 460 AGC BIOLOGICS: COMPANY OVERVIEW
• TABLE 461 AGC BIOLOGICS: PRODUCTS/SERVICES OFFERED
• TABLE 462 AGC BIOLOGICS: DEALS, JANUARY 2021-AUGUST 2024
• TABLE 463 AGC BIOLOGICS: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 464 DR. REDDY'S LABORATORIES LTD.: COMPANY OVERVIEW
• TABLE 465 DR. REDDY'S LABORATORIES LTD.: PRODUCTS/SERVICES OFFERED
• TABLE 466 DR. REDDY'S LABORATORIES LTD.: EXPANSIONS, JANUARY 2021-AUGUST 2024
• TABLE 467 ETHERNA: COMPANY OVERVIEW
• TABLE 468 BOC SCIENCES: COMPANY OVERVIEW
• TABLE 469 BIOMAY AG: COMPANY OVERVIEW
• TABLE 470 CURIA GLOBAL, INC.: COMPANY OVERVIEW
• TABLE 471 JENA BIOSCIENCE GMBH: COMPANY OVERVIEW
• TABLE 472 ENZYNOMICS CO., LTD.: COMPANY OVERVIEW
• TABLE 473 KANEKA EUROGENTEC S.A.: COMPANY OVERVIEW
• TABLE 474 VERNAL BIOSCIENCES: COMPANY OVERVIEW
• TABLE 475 CELLSCRIPT: COMPANY OVERVIEW

List of Figures

• FIGURE 1 MRNA SYNTHESIS & MANUFACTURING MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 MRNA SYNTHESIS & MANUFACTURING MARKET: RESEARCH DESIGN
• FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY RESPONDENT, DESIGNATION, AND REGION
• FIGURE 4 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
• FIGURE 5 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
• FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION FOR PRODUCT MARKET), 2023
• FIGURE 7 MARKET SIZE ESTIMATION: APPROACH 2 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION FOR SERVICE MARKET), 2023
• FIGURE 8 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2023
• FIGURE 9 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
• FIGURE 10 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• FIGURE 11 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: CAGR PROJECTIONS, 2024-2029
• FIGURE 12 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET: CAGR PROJECTIONS, 2024-2029
• FIGURE 13 MRNA SYNTHESIS & MANUFACTURING MARKET: DATA TRIANGULATION METHODOLOGY
• FIGURE 14 MRNA SYNTHESIS & MANUFACTURING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 MRNA SYNTHESIS & MANUFACTURING MARKET, BY SERVICE, 2024 VS. 2029 (USD MILLION)
• FIGURE 16 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 17 MRNA SYNTHESIS & MANUFACTURING SERVICE MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 18 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 19 MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET: GEOGRAPHICAL SNAPSHOT
• FIGURE 20 EXPANDING APPLICATIONS OF MRNA TECHNOLOGY TO DRIVE MARKET
• FIGURE 21 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• FIGURE 22 MRNA SYNTHESIS & MODIFICATION TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 23 MRNA SYNTHESIS & MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 24 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN MRNA SYNTHESIS & MANUFACTURING MARKET
• FIGURE 25 MRNA SYNTHESIS & MANUFACTURING MARKET: VALUE CHAIN ANALYSIS
• FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT, 2021-2023 (USD)
• FIGURE 27 AVERAGE SELLING PRICE TREND, BY CONSUMABLES, 2021-2023 (USD)
• FIGURE 28 AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
• FIGURE 29 MRNA SYNTHESIS & MANUFACTURING MARKET: PATENT ANALYSIS, 2014-2024
• FIGURE 30 MRNA SYNTHESIS & MANUFACTURING MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 31 MRNA SYNTHESIS & MANUFACTURING MARKET: ECOSYSTEM ANALYSIS
• FIGURE 32 MRNA SYNTHESIS & MANUFACTURING MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
• FIGURE 34 KEY BUYING CRITERIA, BY END USER (PRODUCT)
• FIGURE 35 RESEARCH FUNDING FOR MRNA SYNTHESIS & MANUFACTURING BY INSTITUTES AND CENTERS, 2021-2024 (USD MILLION)
• FIGURE 36 IMPACT OF AI ON MRNA SYNTHESIS & MANUFACTURING MARKET
• FIGURE 37 MRNA SYNTHESIS & MANUFACTURING INSTRUMENTS MARKET, BY VOLUME, 2022-2029
• FIGURE 38 NORTH AMERICA: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SNAPSHOT
• FIGURE 39 ASIA PACIFIC: MRNA SYNTHESIS & MANUFACTURING PRODUCT MARKET SNAPSHOT
• FIGURE 40 MRNA SYNTHESIS & MANUFACTURING MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023 (USD MILLION)
• FIGURE 41 MRNA SYNTHESIS & MANUFACTURING MARKET SHARE ANALYSIS, 2023
• FIGURE 42 EV/EBITDA OF KEY VENDORS
• FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 44 MRNA SYNTHESIS & MANUFACTURING MARKET: BRAND/SERVICE COMPARISON
• FIGURE 45 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 46 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY FOOTPRINT
• FIGURE 47 MRNA SYNTHESIS & MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
• FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT (2023)
• FIGURE 51 LONZA: COMPANY SNAPSHOT (2023)
• FIGURE 52 MARVAI LIFESCIENCES: COMPANY SNAPSHOT (2023)
• FIGURE 53 GENSCRIPT: COMPANY SNAPSHOT (2023)
• FIGURE 54 WUXI BIOLOGICS: COMPANY SNAPSHOT (2023)
• FIGURE 55 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
• FIGURE 56 SARTORIUS AG: COMPANY SNAPSHOT (2023)
• FIGURE 57 GENEWIZ: COMPANY SNAPSHOT (2023)
• FIGURE 58 TELESIS BIO INC.: COMPANY SNAPSHOT (2023)
• FIGURE 59 ST PHARM: COMPANY SNAPSHOT (2023)
• FIGURE 60 DR. REDDY'S LABORATORIES LTD.: COMPANY SNAPSHOT (2023)